Pharmacy Website
Clinic Website

Intelligence » Diabetes » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

A Web-Based Coping Intervention by and for Parents of Very Young Children With Type 1 Diabetes: User-Centered Design

Monday, December 17, 2018 -- Background: Management of type 1 diabetes (T1D) among children aged <6 years is exceptionally challenging for parents and caregivers. Metabolic and psychosocial outcomes among very young children with T1D (YC-T1D) are tightly associated with their parents’ ability to meet these challenges. There is scant research testing interventions targeting these issues and few resources to equip health care providers with feasible and effective coping strategies for these parents. User-centered design (UCD) of a continuously accessible Web-based resource could be a mechanism for helping parents of YC-T1D cope more effectively with the complex challenges they face by providing them with information, solutions, and emotional support. Objective: The objectives of this paper are to (1) describe the application of UCD principles to

Low birth weight related to type 2 diabetes, CVD

Thursday, December 13, 2018 -- Birth weight is associated with risk for type 2 diabetes and CVD in a J-shaped manner, and is more pronounced among women, according to findings published in the Journal of the American Heart Association.The meta-analysis aimed to clarify the shape of associations between birth weight, type 2 diabetes and CVD in adults and assessed sex-specific risks, the researchers wrote.“Studies have consistently reported a U-shaped association between birth weight and [type 2 diabetes], while studies examining birth weight and CVD have been inconsistent, reporting an inverse or a U-shaped association,”

Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial

Monday, December 17, 2018 -- AbstractObjectives The authors sought to investigate the impact of diabetes mellitus (DM) on outcomes following contemporary drug-eluting stent (DES) implantation in the BIONICS (BioNIR Ridaforolimus Eluting Coronary Stent System in Coronary Stenosis) trial. Background Patients with DM are at increased risk for adverse events following percutaneous coronary intervention (PCI). Methods A prospective, multicenter, 1:1 randomized trial was conducted to evaluate in a noninferiority design the safety and efficacy of ridaforolimus-eluting stents versus zotarolimus-eluting stents among 1,919 patients undergoing PCI. Randomization was stratified to the presence of medically treated DM, and a pre-specified analysis compared outcomes according to the presence or absence of DM up to 2 years. Results The overall prevalence of DM was 29.1% (559 of 1,919). DM

Link Between Number of Migraines and Diabetes Risk

Monday, December 17, 2018 -- Our results may suggest a potential role of both hyperglycemia and hyperinsulinism on migraine occurrence Continue reading →

Migraine Tied to Lower Diabetes Risk

Monday, December 17, 2018 -- (MedPage Today) -- Prevalence in women decreases long before T2D diagnoses and plateaus after